The LEADER trial was an international, randomised, double-blind, controlled cardiovascular outcomes trial (CVOT)
J Clin Endocrinol Metab 90(4):19291935
If a patient is interested in BPC-157, the discussion should include why they are interested, what condition they are trying to address, what has already been diagnosed, what other treatments have been tried, what medications they take, and what safety questions apply
72(8):1187] [published correction appears in Arthritis Care Res (Hoboken) 2021
SATISFACTION GUARANTEED Each order is backed by an unconditional 90-day guarantee so you can try THRIVE risk-free
By tracking medication use over 12 months, the researchers found that treatment often did not follow a linear path